RENAL SAFETY OF HIGH AND LOW DOSE MAINTENANCE TREATMENT WITH MESALAMINE GRANULES IN ULCERATIVE COLITIS PATIENTS: A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, DOSE-RANGING, 12-MONTHS STUDY

(1) Internal Medicine, Ev Krankenhaus Kalk, Cologne

(2) Clinical Research and Development, Dr Falk Pharma GmbH, Freiburg, Germany



This item was part of the Safety and outcome prediction in IBD session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A34